Copyright
©The Author(s) 2020.
World J Diabetes. Dec 15, 2020; 11(12): 622-643
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.622
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.622
Figure 11 Influence of CL 316243, vanadate, amine oxidase inhibitors and antioxidants on glucose uptake in mouse adipocytes.
Fat cells from wild-type mice were subjected to 2-deoxyglucose (2-DG) uptake in the presence of CL 316243, or catecholamines, insulin and vanadate. A: The β3-adrenoceptors agonist was incubated alone (control, closed diamonds) or with vanadate (open squares) at the indicated concentrations; B: 1 mmol/L adrenaline (open columns) and noradrenaline (black columns) or 100 nmol/L insulin (shaded columns) were incubated with 100 µmol/L vanadate, without (control) or in the presence of pargyline 0.1 mmol/L, or pargyline + semicarbazide 1 mmol/L, or with 1 mmol/L of the antioxidants: N-acetylcysteine, glutathione, ascorbic acid. 2-DG uptake was expressed as the percentage of the insulin effect (which reached 1.73 ± 0.33 nmol 2-DG/100 mg lipids/0 min). The mean ± SE of 4 determination was determined. A significant difference from the respective control was observed at: aP < 0.05, bP < 0.01, cP < 0.001. 2-DG: 2-Deoxyglucose.
- Citation: Fontaine J, Tavernier G, Morin N, Carpéné C. Vanadium-dependent activation of glucose transport in adipocytes by catecholamines is not mediated via adrenoceptor stimulation or monoamine oxidase activity. World J Diabetes 2020; 11(12): 622-643
- URL: https://www.wjgnet.com/1948-9358/full/v11/i12/622.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i12.622